US Stock MarketDetailed Quotes

TLIS Talis Biomedical

Watchlist
  • 4.3600
  • +0.2200+5.31%
Close Aug 16 16:00 ET
  • 4.3000
  • -0.0600-1.38%
Post 20:01 ET
7.94MMarket Cap-138P/E (TTM)

Talis Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
60.97%-6.43M
46.83%-53.24M
16.14%-11.36M
46.48%-11.14M
35.16%-14.27M
62.37%-16.47M
41.57%-100.14M
66.76%-13.54M
72.14%-20.82M
34.11%-22.01M
Net income from continuing operations
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
58.10%-27.01M
Depreciation and amortization
50.57%262K
-91.28%770K
-94.08%211K
-94.47%217K
-82.86%168K
-52.07%174K
459.57%8.83M
280.15%3.56M
1,599.13%3.93M
405.15%980K
Other non cash items
-48.66%403K
55.32%4.3M
-50.73%403K
-53.33%441K
346.58%2.68M
91.93%785K
165.68%2.77M
2,626.67%818K
94.85%945K
55.58%599K
Change In working capital
147.81%371K
55.45%-3.42M
-88.65%469K
104.34%42K
-245.31%-3.16M
94.04%-776K
-187.10%-7.69M
125.47%4.13M
97.55%-967K
-92.42%2.17M
-Change in receivables
-76.37%43K
307.20%259K
-136.00%-45K
160.10%528K
-120.67%-406K
107.53%182K
-143.40%-125K
247.22%125K
299.02%203K
1,778.63%1.96M
-Change in inventory
----
----
----
--0
----
----
----
----
--192K
--1.28M
-Change in prepaid assets
-94.11%76K
211.09%1.88M
-53.52%628K
-56.89%691K
-152.29%-731K
134.45%1.29M
-94.85%604K
288.22%1.35M
-15.85%1.6M
-53.69%1.4M
-Change in payables and accrued expense
111.20%252K
37.55%-5.56M
-447.45%-2.18M
70.42%-876K
88.67%-255K
47.96%-2.25M
-468.32%-8.91M
105.05%628K
92.82%-2.96M
-108.67%-2.25M
-Change in other current assets
----
--0
--0
--0
----
----
--741K
---239K
--0
---1K
-Change in other current liabilities
----
----
----
-7,425.00%-301K
----
----
----
----
96.40%-4K
-29.34%-216K
Cash from discontinued investing activities
Operating cash flow
60.97%-6.43M
46.83%-53.24M
16.14%-11.36M
46.48%-11.14M
35.16%-14.27M
62.37%-16.47M
41.57%-100.14M
66.76%-13.54M
72.14%-20.82M
34.11%-22.01M
Investing cash flow
Cash flow from continuing investing activities
225.00%30K
69.91%-486K
289.80%93K
91.86%-70K
-143.72%-485K
95.27%-24K
43.65%-1.62M
95.04%-49K
-13.31%-860K
52.84%-199K
Net PPE purchase and sale
225.00%30K
69.91%-486K
289.80%93K
91.86%-70K
-143.72%-485K
95.27%-24K
43.65%-1.62M
95.04%-49K
-13.31%-860K
52.84%-199K
Cash from discontinued investing activities
Investing cash flow
225.00%30K
69.91%-486K
289.80%93K
91.86%-70K
-143.72%-485K
95.27%-24K
43.65%-1.62M
95.04%-49K
-13.31%-860K
52.84%-199K
Financing cash flow
Cash flow from continuing financing activities
-93.94%2K
-91.87%33K
0
0
0
-89.49%33K
-99.83%406K
0
-90.82%92K
0
Proceeds from stock option exercised by employees
-93.94%2K
-91.87%33K
--0
--0
--0
-89.49%33K
-78.44%406K
--0
-90.82%92K
--0
Cash from discontinued financing activities
Financing cash flow
-93.94%2K
-91.87%33K
--0
--0
--0
-89.49%33K
-99.83%406K
--0
-90.82%92K
--0
Net cash flow
Beginning cash position
-40.69%78.27M
-43.44%131.97M
-38.49%89.54M
-39.72%100.75M
-39.00%115.51M
-43.44%131.97M
34.76%233.31M
-46.95%145.56M
-52.09%167.15M
-50.61%189.36M
Current changes in cash
61.14%-6.4M
47.02%-53.69M
17.13%-11.26M
48.06%-11.21M
33.55%-14.76M
62.56%-16.46M
-268.41%-101.35M
66.90%-13.59M
71.02%-21.59M
35.72%-22.21M
End cash Position
-37.77%71.88M
-40.69%78.27M
-40.69%78.27M
-38.49%89.54M
-39.72%100.75M
-39.00%115.51M
-43.44%131.97M
-43.44%131.97M
-46.95%145.56M
-52.09%167.15M
Free cash flow
61.02%-6.43M
47.20%-53.73M
17.13%-11.26M
48.28%-11.21M
33.55%-14.76M
62.75%-16.49M
41.61%-101.75M
67.43%-13.59M
71.28%-21.68M
34.35%-22.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 60.97%-6.43M46.83%-53.24M16.14%-11.36M46.48%-11.14M35.16%-14.27M62.37%-16.47M41.57%-100.14M66.76%-13.54M72.14%-20.82M34.11%-22.01M
Net income from continuing operations 26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M58.10%-27.01M
Depreciation and amortization 50.57%262K-91.28%770K-94.08%211K-94.47%217K-82.86%168K-52.07%174K459.57%8.83M280.15%3.56M1,599.13%3.93M405.15%980K
Other non cash items -48.66%403K55.32%4.3M-50.73%403K-53.33%441K346.58%2.68M91.93%785K165.68%2.77M2,626.67%818K94.85%945K55.58%599K
Change In working capital 147.81%371K55.45%-3.42M-88.65%469K104.34%42K-245.31%-3.16M94.04%-776K-187.10%-7.69M125.47%4.13M97.55%-967K-92.42%2.17M
-Change in receivables -76.37%43K307.20%259K-136.00%-45K160.10%528K-120.67%-406K107.53%182K-143.40%-125K247.22%125K299.02%203K1,778.63%1.96M
-Change in inventory --------------0------------------192K--1.28M
-Change in prepaid assets -94.11%76K211.09%1.88M-53.52%628K-56.89%691K-152.29%-731K134.45%1.29M-94.85%604K288.22%1.35M-15.85%1.6M-53.69%1.4M
-Change in payables and accrued expense 111.20%252K37.55%-5.56M-447.45%-2.18M70.42%-876K88.67%-255K47.96%-2.25M-468.32%-8.91M105.05%628K92.82%-2.96M-108.67%-2.25M
-Change in other current assets ------0--0--0----------741K---239K--0---1K
-Change in other current liabilities -------------7,425.00%-301K----------------96.40%-4K-29.34%-216K
Cash from discontinued investing activities
Operating cash flow 60.97%-6.43M46.83%-53.24M16.14%-11.36M46.48%-11.14M35.16%-14.27M62.37%-16.47M41.57%-100.14M66.76%-13.54M72.14%-20.82M34.11%-22.01M
Investing cash flow
Cash flow from continuing investing activities 225.00%30K69.91%-486K289.80%93K91.86%-70K-143.72%-485K95.27%-24K43.65%-1.62M95.04%-49K-13.31%-860K52.84%-199K
Net PPE purchase and sale 225.00%30K69.91%-486K289.80%93K91.86%-70K-143.72%-485K95.27%-24K43.65%-1.62M95.04%-49K-13.31%-860K52.84%-199K
Cash from discontinued investing activities
Investing cash flow 225.00%30K69.91%-486K289.80%93K91.86%-70K-143.72%-485K95.27%-24K43.65%-1.62M95.04%-49K-13.31%-860K52.84%-199K
Financing cash flow
Cash flow from continuing financing activities -93.94%2K-91.87%33K000-89.49%33K-99.83%406K0-90.82%92K0
Proceeds from stock option exercised by employees -93.94%2K-91.87%33K--0--0--0-89.49%33K-78.44%406K--0-90.82%92K--0
Cash from discontinued financing activities
Financing cash flow -93.94%2K-91.87%33K--0--0--0-89.49%33K-99.83%406K--0-90.82%92K--0
Net cash flow
Beginning cash position -40.69%78.27M-43.44%131.97M-38.49%89.54M-39.72%100.75M-39.00%115.51M-43.44%131.97M34.76%233.31M-46.95%145.56M-52.09%167.15M-50.61%189.36M
Current changes in cash 61.14%-6.4M47.02%-53.69M17.13%-11.26M48.06%-11.21M33.55%-14.76M62.56%-16.46M-268.41%-101.35M66.90%-13.59M71.02%-21.59M35.72%-22.21M
End cash Position -37.77%71.88M-40.69%78.27M-40.69%78.27M-38.49%89.54M-39.72%100.75M-39.00%115.51M-43.44%131.97M-43.44%131.97M-46.95%145.56M-52.09%167.15M
Free cash flow 61.02%-6.43M47.20%-53.73M17.13%-11.26M48.28%-11.21M33.55%-14.76M62.75%-16.49M41.61%-101.75M67.43%-13.59M71.28%-21.68M34.35%-22.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg